Interview: Ulf Geumann on Mesenchymal Stem Cells in Immunotherapy

InfoWeb Marketplace

Thursday, May 17, 2018Description :
Dr. Ulf Geumann, Group Leader Preclinical Development, apceth Biopharma GmbH, summarizes his talk on harnessing the potential of mesenchymal stem cells. More information about the Sartorius Research Xchange Forum on Trends and Challenges in Regenerative Medicine and Cell Therapy 2018:

Grouped quotes (0)